Inventor
JACKSON PHILIP STEPHEN
GB13 patents
⚠️ This page may combine multiple inventors who share the name “JACKSON PHILIP STEPHEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
12 patentsUS6172077B1Jan 9, 2001
Spiro-azacyclic derivatives and their use as therapeutic agents
MERCK SHARP & DOHME149 citations97
US6114315ASep 5, 2000
Use of NK-1 receptor antagonists for treating major depressive disorders with anxiety
MERCK SHARP & DOHME26 citations92
US5977104ANov 2, 1999
Use of NK-1 receptor antagonists for treating bipolar disorders
MERCK SHARP & DOHME29 citations92
US5952315ASep 14, 1999
Use of NK-1 receptor antagonists for treating bipolar disorders
MERCK SHARP & DOHME34 citations92
US6271230B1Aug 7, 2001
Use of NK-1 receptor antagonists for treating cognitive disorders
MERCK SHARP & DOHME6 citations74
US6071927AJun 6, 2000
Spiro-piperidine derivatives and their use as therapeutic agents
MERCK SHARP & DOHME13 citations74
US5925627AJul 20, 1999
Use of NK-1 receptor antagonists for treating movement disorders
MERCK SHARP & DOHME7 citations74
US6100256AAug 8, 2000
Use of NK-1 receptors antagonists for treating schizophrenic disorders
MERCK SHARP & DOHME7 citations73
US6087348AJul 11, 2000
Use of NK-1 receptor antagonists for treating stress disorders
MERCK SHARP & DOHME3 citations63
US5919781AJul 6, 1999
Use of NK-1 receptor antogonists for treating substance use disorders
MERCK SHARP & DOHME5 citations63
US6096729AAug 1, 2000
Use of NK-1 receptor antagonists for treating amnestic disorders
MERCK SHARP & DOHME0 citations52
US6613765B1Sep 2, 2003
Use of NK-1 receptor antagonists for treating major depressive disorders
MERCK SHARP & DOHME0 citations51